drugset / Trial / NCT07693153
The Effects of Psilocybin on Social Connectedness
RandomizedParallel-groupTriple-blindOther
Summary
The study is a randomized, double-blind, placebo-controlled, expectancy-controlled, mechanistic trial. This study looks to explore whether a single dose of psilocybin (25mg) reduces amygdala reactivity to negative socioemotional stimuli during the Facial Emotion Recognition Task (FERT) compared to a placebo in adults who feel lonely or those with unresolved grief symptoms.
Timeline
- Start
- 2026-08-31
- Primary completion
- 2031-12-15
- Completion
- 2031-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Psilocybin | Other / unclassified | 25 mg | — |
Indications
No indication recorded.